This clinical trial studies how well a web-based intervention called Eat Right, Screen Right works in promoting colorectal cancer (CRC) screening. CRC accounts for about 8% of new cancer cases in the United States. Among several lifestyle behaviors related to CRC risk are alcohol, red meat, and processed meat consumption. Evaluating nutritional status is considered a key component of the patient care process, and when done effectively, can help patients understand which foods increase CRC risk. The Eat Right, Screen Right intervention involves an interactive web-based conversation with a virtual health assistant that talks to participants about nutrition and CRC screening, as well as a self-paced course that contains five additional brief lessons. The Eat Right, Screen Right intervention may be able to help adult learners manage nutrition risks and screening options for CRC prevention.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT07393906.
Locations matching your search criteria
United States
Florida
Gainesville
UF Health Cancer Institute - GainesvilleStatus: Active
Contact: Melissa Vilaro
Phone: 352-392-1778
PRIMARY OBJECTIVE:
I. To conduct a pilot test of a web-based CRC prevention and screening intervention to explore intentions to obtain colorectal cancer screening.
SECONDARY OBJECTIVES:
I. Explore participants’ engagement with information about colorectal cancer screening guidelines and modalities (e.g., home stool tests, colonoscopy, others) and other cancer prevention lifestyle behaviors via a scripted virtual conversation and self-paced, web-based education modules.
II. Explore participants’ intentions to apply behavior change strategies to support cancer prevention behaviors.
III. Explore participants’ understanding of the modifiable dietary behaviors that affect colorectal cancer risk.
OUTLINE:
Participants interact with a virtual health assistant (VHA), followed by educational information through 5 audio-visual content modules over 10-13 minutes each on study.
Trial PhaseNo phase specified
Trial Typeprevention
Lead OrganizationUF Health Cancer Institute - Gainesville
Principal InvestigatorMelissa Vilaro